Catalent, a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, has entered into an agreement to acquire the manufacturing and packaging operations of Acorda Therapeutics, a developer of therapies to restore function and improve the lives of people with neurological disorders. The acquisition complements Catalent’s status as a premier U.S.-based partner for companies across dry po...